Researchers at UCLA have developed a novel device that allows access to therapeutic and diagnostic devices into the left ventricle from the venous side. This device will create a platform for accessing left-sided structures including the aortic and mitral valves.
UCLA researchers in the Division of Cardiology at the Geffen School of Medicine have developed novel devices and methods for allowing entirely intravascular access to the left ventricle, thereby precluding access via the apex of the heart percutaneously or by surgery.
- No longer requires trans-apical surgery or crossing the aortic or mitral valves via arterial approach or trans-atrial septal approach
- Minimizes injury to the ventricular septum or coronary arteries
Left ventricular access in the field of cardiac electrophysiology and cardiac surgery
Name: UCLA Technology Development Group